xanthine has been researched along with Choreoathetosis Self-Mutilation Hyperuricemia Syndrome in 22 studies
7H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-7 is protonated.
9H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.
Excerpt | Relevance | Reference |
---|---|---|
"Lesch-Nyhan syndrome is a rare inborn error of purine metabolism marked by a complete deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT)." | 7.88 | Xanthine calculi in a patient with Lesch-Nyhan syndrome and factor V Leiden treated with allopurinol: case report. ( Peppas, DS; Rosenberg, E; Shields, LBE, 2018) |
"It is the intention of this report to identify appropriate analytical tests which allow for the monitoring of allopurinol treatment of patients with Lesch-Nyhan syndrome and the prevention of uric acid or xanthine lithiasis." | 7.72 | [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy]. ( Muche, J; Rebentisch, G; Stolz, S, 2004) |
"A rat neuroma cell line (B103 4C), deficient of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), was utilized as a model tissue in search for the biochemical basis of the Lesch-Nyhan syndrome (LNS)." | 7.68 | Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line. ( Bromberg, Y; Brosh, S; Sidi, Y; Sperling, O; Zoref-Shani, E, 1993) |
"We report a case of Lesch-Nyhan syndrome (LNS) with urinary xanthine calculi." | 7.68 | Extracorporeal shock wave lithotripsy and xanthine calculi in Lesch-Nyhan syndrome. ( Kusuyama, H; Morino, M; Okada, K; Shiigai, N, 1992) |
"In order to explain features of severe hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency, the Lesch-Nyhan syndrome, a continuous supply of substrate, hypoxanthine, for the enzyme must be generated." | 7.68 | The pathogenesis of the Lesch-Nyhan syndrome: ATP use is positively related to hypoxanthine supply to hypoxanthine guanine phosphoribosyltransferase. ( Greenwood, R; Harkness, RA; McCreanor, GM, 1991) |
"A Japanese boy with Lesch-Nyhan syndrome who passed xanthine calculi is reported." | 7.67 | Xanthine calculi in the patient with the Lesch-Nyhan syndrome associated with urinary tract infection. ( Ichikawa, Y; Koide, T; Mimaki, T; Oka, T; Sonoda, T; Takaha, M; Utsunomiya, M, 1985) |
"Treatment with allopurinol was associated to a mean reduction of serum urate concentration of 50%, and was normalized in all patients." | 5.33 | Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients. ( Prior, C; Puig, JG; Torres, RJ, 2006) |
"Lesch-Nyhan syndrome is a rare inborn error of purine metabolism marked by a complete deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT)." | 3.88 | Xanthine calculi in a patient with Lesch-Nyhan syndrome and factor V Leiden treated with allopurinol: case report. ( Peppas, DS; Rosenberg, E; Shields, LBE, 2018) |
"It is the intention of this report to identify appropriate analytical tests which allow for the monitoring of allopurinol treatment of patients with Lesch-Nyhan syndrome and the prevention of uric acid or xanthine lithiasis." | 3.72 | [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy]. ( Muche, J; Rebentisch, G; Stolz, S, 2004) |
"A rat neuroma cell line (B103 4C), deficient of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), was utilized as a model tissue in search for the biochemical basis of the Lesch-Nyhan syndrome (LNS)." | 3.68 | Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line. ( Bromberg, Y; Brosh, S; Sidi, Y; Sperling, O; Zoref-Shani, E, 1993) |
"We report a case of Lesch-Nyhan syndrome (LNS) with urinary xanthine calculi." | 3.68 | Extracorporeal shock wave lithotripsy and xanthine calculi in Lesch-Nyhan syndrome. ( Kusuyama, H; Morino, M; Okada, K; Shiigai, N, 1992) |
"In order to explain features of severe hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency, the Lesch-Nyhan syndrome, a continuous supply of substrate, hypoxanthine, for the enzyme must be generated." | 3.68 | The pathogenesis of the Lesch-Nyhan syndrome: ATP use is positively related to hypoxanthine supply to hypoxanthine guanine phosphoribosyltransferase. ( Greenwood, R; Harkness, RA; McCreanor, GM, 1991) |
"Lesch-Nyhan syndrome is a rare X-linked recessive disorder of purine metabolism associated with a virtually complete deficiency of the enzyme hypoxanthine-guanine phosphoribosyl-transferase (HPRT)." | 3.67 | Renal oxypurine deposition in Lesch-Nyhan syndrome: sonographic evaluation. ( Parker, BR; Stevens, SK, 1989) |
"A Japanese boy with Lesch-Nyhan syndrome who passed xanthine calculi is reported." | 3.67 | Xanthine calculi in the patient with the Lesch-Nyhan syndrome associated with urinary tract infection. ( Ichikawa, Y; Koide, T; Mimaki, T; Oka, T; Sonoda, T; Takaha, M; Utsunomiya, M, 1985) |
"We report a case of urate overproduction owing to the Lesch-Nyhan syndrome (deficiency of hypoxanthine-guanine phosphoribosyltransferase)." | 3.67 | Xanthine-containing calculi during allopurinol therapy. ( Emmerson, BT; Gordon, RB; Keough, D; Kranen, S, 1985) |
"Treatment with allopurinol was associated to a mean reduction of serum urate concentration of 50%, and was normalized in all patients." | 1.33 | Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients. ( Prior, C; Puig, JG; Torres, RJ, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (27.27) | 18.7374 |
1990's | 8 (36.36) | 18.2507 |
2000's | 4 (18.18) | 29.6817 |
2010's | 4 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shields, LBE | 1 |
Peppas, DS | 1 |
Rosenberg, E | 1 |
Ng, N | 1 |
Kaur, A | 1 |
Shenoy, M | 1 |
Jacomelli, G | 1 |
Baldini, E | 1 |
Mugnaini, C | 1 |
Micheli, V | 1 |
Bernardini, G | 1 |
Santucci, A | 1 |
Zennaro, C | 1 |
Tonon, F | 1 |
Zarattini, P | 1 |
Clai, M | 1 |
Corbelli, A | 1 |
Carraro, M | 1 |
Marchetti, M | 1 |
Ronda, L | 1 |
Paredi, G | 1 |
Rastaldi, MP | 1 |
Percudani, R | 1 |
Bavaresco, CS | 1 |
Zugno, AI | 1 |
Tagliari, B | 1 |
Wannmacher, CM | 1 |
Wajner, M | 1 |
Wyse, AT | 1 |
Rebentisch, G | 1 |
Stolz, S | 1 |
Muche, J | 1 |
Pais, VM | 1 |
Lowe, G | 1 |
Lallas, CD | 1 |
Preminger, GM | 1 |
Assimos, DG | 1 |
Torres, RJ | 2 |
Prior, C | 1 |
Puig, JG | 3 |
Page, T | 1 |
Barshop, B | 1 |
Yu, AL | 1 |
Nyhan, WL | 1 |
Roscioni, G | 1 |
Farnetani, MA | 1 |
Pagani, R | 1 |
Pizzichini, M | 1 |
Marinello, E | 1 |
Porcelli, B | 1 |
Zoref-Shani, E | 1 |
Bromberg, Y | 1 |
Brosh, S | 1 |
Sidi, Y | 1 |
Sperling, O | 1 |
Volpe, P | 1 |
Peyrottes, A | 1 |
Lammle, M | 1 |
Saquet, D | 1 |
Choquenet, C | 1 |
Mateos, FA | 2 |
Buño, AS | 1 |
Morino, M | 1 |
Shiigai, N | 1 |
Kusuyama, H | 1 |
Okada, K | 1 |
Ramos, TH | 1 |
Jiménez, ML | 1 |
Romera, NM | 1 |
González, AG | 1 |
Harkness, RA | 1 |
McCreanor, GM | 1 |
Greenwood, R | 1 |
Stevens, SK | 1 |
Parker, BR | 1 |
López Jiménez, M | 1 |
García Puig, J | 1 |
Mateos Antón, F | 1 |
Ramos Hernández, T | 1 |
Pascual Castroviejo, I | 1 |
Ortiz Vázquez, J | 1 |
Kish, SJ | 1 |
Fox, IH | 1 |
Kapur, BM | 1 |
Lloyd, K | 1 |
Hornykiewicz, O | 1 |
Hiraishi, K | 1 |
Nakamura, S | 1 |
Yamamoto, S | 1 |
Kurokawa, K | 1 |
Oka, T | 1 |
Utsunomiya, M | 1 |
Ichikawa, Y | 1 |
Koide, T | 1 |
Takaha, M | 1 |
Mimaki, T | 1 |
Sonoda, T | 1 |
Kranen, S | 1 |
Keough, D | 1 |
Gordon, RB | 1 |
Emmerson, BT | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00004314] | Phase 2 | 2 participants | Interventional | 1996-02-29 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
22 other studies available for xanthine and Choreoathetosis Self-Mutilation Hyperuricemia Syndrome
Article | Year |
---|---|
Xanthine calculi in a patient with Lesch-Nyhan syndrome and factor V Leiden treated with allopurinol: case report.
Topics: Allopurinol; Antimetabolites; Child; Factor V; Humans; Kidney Calculi; Lesch-Nyhan Syndrome; Male; P | 2018 |
Recurrent kidney stones in a child with Lesch-Nyhan syndrome: Answers.
Topics: Allopurinol; Child, Preschool; Fluid Therapy; Humans; Hydrogen-Ion Concentration; Hypoxanthine Phosp | 2019 |
Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
Topics: Allopurinol; Cells, Cultured; Enzyme Inhibitors; Humans; Hyperuricemia; Hypoxanthine; Hypoxanthine P | 2019 |
The renal phenotype of allopurinol-treated HPRT-deficient mouse.
Topics: Allopurinol; Animals; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Mice; Mice, Knoc | 2017 |
Inhibition of Na+, K+-ATPase activity in rat striatum by the metabolites accumulated in Lesch-Nyhan disease.
Topics: Analysis of Variance; Animals; Animals, Newborn; Corpus Striatum; Dose-Response Relationship, Drug; | 2004 |
[Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
Topics: Allopurinol; Child; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Hypoxanthine; Kidney | 2004 |
Xanthine urolithiasis.
Topics: Adolescent; Allopurinol; Child; Enzyme Inhibitors; Female; Fluid Therapy; Humans; Hydrogen-Ion Conce | 2006 |
Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
Topics: Adolescent; Adult; Allopurinol; Child; Child, Preschool; Follow-Up Studies; Humans; Hypoxanthine; Hy | 2006 |
Treatment of Lesch-Nyhan syndrome with AICAR.
Topics: Adolescent; Aminoimidazole Carboxamide; Humans; Hypoxanthine; Hypoxanthines; Infusions, Intravenous; | 1994 |
Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment.
Topics: Child; Erythrocytes; Fibroblasts; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Hypo | 1994 |
Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line.
Topics: Adenine; Adenine Nucleotides; Animals; Formates; Guanine; Hypoxanthine; Hypoxanthine Phosphoribosylt | 1993 |
[Xanthine urinary calculus in a patient with Lesch-Nyhan syndrome. Apropos of a case].
Topics: Allopurinol; Antimetabolites; Child; Enzyme Inhibitors; Follow-Up Studies; Humans; Kidney Calculi; L | 1997 |
Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Female; Heterozygote; Humans; Hypoxanthine; Hypoxanth | 1998 |
Extracorporeal shock wave lithotripsy and xanthine calculi in Lesch-Nyhan syndrome.
Topics: Allopurinol; Humans; Infant; Kidney Calculi; Lesch-Nyhan Syndrome; Lithotripsy; Male; Xanthine; Xant | 1992 |
Prenatal diagnosis of Lesch-Nyhan syndrome by purine analysis of amniotic fluid and cordocentesis.
Topics: Adult; Amniotic Fluid; Female; Fetal Blood; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransfe | 1991 |
The pathogenesis of the Lesch-Nyhan syndrome: ATP use is positively related to hypoxanthine supply to hypoxanthine guanine phosphoribosyltransferase.
Topics: Adenosine Triphosphate; Adult; Aging; Body Mass Index; Creatinine; Exercise; Female; Humans; Hypoxan | 1991 |
Renal oxypurine deposition in Lesch-Nyhan syndrome: sonographic evaluation.
Topics: Allopurinol; Child; Humans; Hypoxanthine; Hypoxanthines; Kidney Calculi; Lesch-Nyhan Syndrome; Male; | 1989 |
[Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
Topics: Adolescent; Adult; Allopurinol; Blood-Brain Barrier; Child; Child, Preschool; Humans; Hypoxanthine; | 1989 |
Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome.
Topics: Adolescent; Adult; Cerebral Cortex; gamma-Aminobutyric Acid; Humans; Hypoxanthine; Hypoxanthines; In | 1985 |
Prevention of xanthine stone formation by augmented dose of allopurinol in the Lesch-Nyhan syndrome.
Topics: Adolescent; Allopurinol; Calculi; Humans; Lesch-Nyhan Syndrome; Male; Xanthine; Xanthines | 1987 |
Xanthine calculi in the patient with the Lesch-Nyhan syndrome associated with urinary tract infection.
Topics: Allopurinol; Child; Combined Modality Therapy; Enterococcus faecalis; Humans; Kidney Calculi; Lesch- | 1985 |
Xanthine-containing calculi during allopurinol therapy.
Topics: Adult; Allopurinol; Humans; Hypoxanthine; Hypoxanthines; Kidney Calculi; Lesch-Nyhan Syndrome; Male; | 1985 |